AGP Executive Report

Ireland Vape Alert: Ireland’s HSE says high-risk synthetic cannabinoids (including HHC-related compounds and potent synthetics) were found in some vapes, vape juice and edibles sold in shops and on the illicit market, with multiple products linked to serious harms like psychosis and severe intoxication. CBD Retail Reality Check: A separate wellness-industry piece argues the “single-ingredient” CBD era is fading as formulators return to multi-compound blends, reflecting how whole-plant traditions may not match isolated-ingredient results. South Dakota Medical Cannabis: South Dakota lawmakers heard that federal reclassification of medical marijuana could unlock tax deductions and banking access, but officials say they still lack clear details on the broader impact. Georgia Mail Delivery: Georgia is considering allowing medical marijuana to be shipped directly to patients via mail couriers after federal scheduling changes, though legal arguments are still being contested. Mental Health Warning: A major Australian meta-analysis links cannabis use to an earlier onset of psychosis, with the gap widening for people who develop psychosis in their 30s. Nigeria Cannabis Policy Fight: Omoyele Sowore blasted NDLEA for destroying cannabis farms in Edo State, calling for legalisation and regulation instead.

DEA Rescheduling Fight: DEA and anti-marijuana groups filed final briefs in the hearing over the Trump administration’s proposal to move cannabis from Schedule I to Schedule III, with DEA arguing accepted medical use and safety under supervision. Clinical Evidence: A UNSW meta-analysis found cannabis users develop psychosis about 2.5 years earlier on average, with the gap widening to 6+ years for people in their late 20s and 30s. M&A Watch: Curaleaf launched a takeover bid for Aurora Cannabis valued around US$260M, offering Curaleaf shares plus cash and seeking regulatory approval. Public Health & Safety: A WA man died at Bass Canyon after ingesting drugs bought at the festival; investigators arrested an alleged dealer and cited cocaine, ketamine, and MDMA. Regulatory Crackdown: Connecticut AG William Tong announced a smoke shop will stay permanently closed and pay a $100K penalty for repeated cannabis-law violations. State Policy: South Dakota reported a 1,072% jump in medical patients licensed to home-grow, and lawmakers discussed tightening rules. Research on Anxiety & Reward: Animal research linked cannabinoid-system changes to stronger alcohol reward learning in persistent anxiety-like behavior. Industry Access: The Artist Tree expanded its free Compassion Program to Dixon ahead of its first New York location.

Research Funding: Canada is putting $24M into a Cannabis and Brain Health Consortium with 10 research teams studying cannabis’s effects on sleep, prenatal exposure, and conditions like psychosis, PTSD, and epilepsy. Clinical & Mental Health: Paris Jackson says she underwent electroconvulsive therapy for severe depression after being “centimeters away” from suicide, describing the procedure and side effects. Policy & Access: South Dakota’s medical cannabis program is expanding fast, with home cultivation licenses up 1,072% (61 to 715) and plans for digital medical IDs, though regulators want tighter oversight. Hemp Regulation Shock: Virginia’s new hemp rules cap total THC at 2mg per package, pushing at least one retailer to close and raising concerns for small businesses. Market & Pricing: Ohio recreational cannabis remains far pricier than Michigan, with a big incentive for cross-border buying as a new Ohio law makes bringing cannabis back a crime. Industry Pipeline: Neurotech reports clinically meaningful paediatric autism outcomes from a broad-spectrum cannabinoid study and locks in a cultivation partnership. Public Safety: Multiple US agencies are ramping DUI enforcement and checkpoints for Labor Day, explicitly warning that cannabis can impair driving. Enforcement: Nigeria’s NDLEA says it destroyed 329,865kg of illicit drugs worth about ₦301B in Lagos, including cannabis varieties.

Impaired Driving Crackdown: Delaware’s “Drive Sober or Get Pulled Over” campaign ramps up for Labor Day, warning that impairment includes prescription meds, cannabis, and other drugs—not just alcohol. Regulatory Accuracy: Massachusetts cannabis regulators found 13 of 63 retail and medical flower products had THC labels outside the state’s acceptable range, pushing for better label accuracy for patient dosing. Medical Delivery Expansion: Georgia’s medical cannabis commission is considering rules to allow delivery to cardholders via USPS and third-party couriers, with guardrails and public comment. Hemp Legal Fight (US): A hemp company challenges DEA claims that synthetic HHC is illegal, arguing the agency’s stance is undermined in ongoing appeals. Hemp/THC Rules Tighten (US): Virginia’s new hemp THC limits took effect after a judge declined to delay, reshaping what products retailers can sell. Clinical Research: A study links cannabis use in adults with HIV to higher fall risk, but the association fades after adjustments. PTSD & THC-Derived Treatment: New Nature Medicine findings report a marijuana-derived medication sharply reduced PTSD nightmares for many patients. Market/Industry: Artelo Biosciences received a patent notice of allowance for its cannabinoid agonist ART27.13 formulation in Phase 2 studies. Public Health Trend: CDC data show predicted US drug overdose deaths fell 12.3% over the prior 12 months. Enforcement (Nigeria): NDLEA destroyed about 329,865.585 kg of illicit drugs in Lagos valued at N301.058 billion, including cannabis varieties.

Medicinal Cannabis Milestone (UK): A boy with severe epilepsy who helped change UK medicinal cannabis law is now thriving and seizure-free at 21, after cannabis-based treatment stopped hundreds of daily seizures. Clinical Safety & Prescribing Controls (Thailand): Thailand’s health authorities warn dentists not to pre-sign cannabis prescription forms without examining and diagnosing patients, citing potential legal and ethical breaches. Cardiovascular Study (US): A new study finds habitual cannabis users had about 9% fewer premature heartbeats on days they inhaled cannabis versus days they abstained, adding nuance to heart-risk questions. Regulated Market Access (Australia): ASX cannabis stocks Vitura Health, Little Green Pharma, Cann Group and ECS Botanics draw attention for operating details like distribution reach, regulatory execution and cultivation efficiency. Hemp Crackdown Fight (Hawaii): A dispensary owner challenges Hawaii’s crackdown on hemp-derived THC products sold without medical cards, arguing it improperly recriminalizes federally legal hemp. Aviation Drug Testing (India): Air India pilots face further scrutiny after additional preliminary drug-test failures tied to the Phuket-Delhi incident, with results pending confirmation.

Federal Rescheduling: A key Monday deadline is set in the DEA’s marijuana rescheduling fight, after an administrative hearing ended July 15; optional post-hearing briefs are due Aug. 17, with a recommendation expected before any final agency decision. State Hemp Crackdown (Legal Challenge): Hawaii officials’ crackdown on hemp-derived THC products is being challenged in federal court by an Oʻahu dispensary owner, arguing the state is improperly re-criminalizing federally legal hemp. Policy Fight in Nebraska: Nebraska’s LB1072—sweeping cash transfers and major program changes—faces heavy opposition in the Legislature, with multiple floor votes showing strong no counts. Medical Cannabis & Safety: Sri Lanka’s transport drug-testing program found nearly 10% of bus staff positive for drugs, including cannabis, as authorities expand screening. Industry Moves: Curaleaf’s $272M bid for Aurora Cannabis signals consolidation momentum in global medical cannabis. Enforcement & Courts: Multiple cases this week highlight ongoing cannabis-related policing and court outcomes, including drug-driving convictions and large cannabis seizures.

M&A Watch: Curaleaf’s unsolicited $272M bid for Aurora Cannabis signals faster consolidation in medical cannabis, with Canopy Growth flagged as a possible next target. Hemp Policy Shock: A U.S. Congress debate over a nationwide hemp-derived intoxicants ban has Lancaster County businesses and farmers bracing for a Nov. 12 shift that could squeeze THC product loopholes. Medical Cannabis Access: Georgia’s medical cannabis program enrollment is spiking after a law change, while Nebraska’s LB1072 fight centers on major fund transfers that could indirectly affect public health and related programs. Public Health & Safety: The CDC reports a surge in ER diagnoses for severe marijuana-related vomiting illness after a new diagnosis code, and Ireland’s HSE warns festival-goers about potent new drugs including pink cocaine and synthetic cannabinoids. Enforcement & Seizures: Ireland charges two men after a €1.2m Dublin cannabis haul tied to a burglary, while Nigeria’s Ogun command reports N3.57bn in smuggled goods including cannabis parcels. Aviation Risk Debate: India’s Air India pilot cannabis test story is raising questions, though officials note a positive result doesn’t automatically prove impairment during flight.

Aviation Safety: Air India’s Phuket–Delhi incident is back in focus after reports of a positive cannabis test for the captain; investigators stress a positive result doesn’t automatically prove impairment while flying. Public Health: The CDC warns ER visits tied to cannabis hyperemesis syndrome are surging after a new diagnostic code improved tracking, with the biggest jump among teens and young women. Legal/Policy: Virginia hemp businesses lost a bid to pause a new rule that bans many hemp products over a THC-per-package threshold, while Nebraska lawmakers continue pushing LB1072 amid heavy opposition over cash reserve and fund-transfer changes. Enforcement & Courts: Dublin police charged two men after a burglary linked to a €1.2m cannabis haul, and a UK case highlights alleged drug-driving after cannabis edibles. Industry & Access: Minnesota’s Blue Ox cannabis store opened with a focus on education, and St. Kitts and Nevis launched registration for a Traditional Cultivator Programme orientation to feed the regulated medicinal market. Business Results: Avicanna reported Q2 2026 financial gains and progress toward profitability, with proprietary product growth and a QUIX™ launch planned for Q3.

Public Health Warning: The CDC says ER visits for cannabis hyperemesis syndrome are surging after a new diagnosis code, with cases now showing up far more often and rising sharply among teens and young women. Medical Access Update: Georgia’s medical cannabis regulators propose rules to allow home delivery to registered patients and to long-term care facilities, with a public hearing set for Sept. 16. Regulatory Courtroom Clash: A federal judge refused to pause Virginia’s new hemp rules that would ban many products over a 2mg THC-per-package limit, keeping the change on track. Industry & Finance: Avicanna reported Q2 2026 results with improving gross margins and progress toward profitability, while Avicanna’s QUIX™ tech is moving toward a Q3 commercial launch. Enforcement & Safety: Police in Dublin charged two men over a €1.2m cannabis seizure tied to a burglary, and a UK case highlighted alleged synthetic cannabinoid involvement in a violent incident. Driving Under the Influence: A Lancashire court case tied a fatal crash to cannabis edibles, and local agencies continue DUI checkpoint campaigns that include cannabis impairment.

Research Funding: Canada is putting $24M into a national cannabis-and-brain health consortium via CIHR, aiming to clarify long-term mental health impacts for youth, pregnant people, frequent users, and higher-risk groups. Cardiology & Safety: A UCSF study in the Journal of the American College of Cardiology reports habitual inhaled cannabis users had about 9% fewer premature heartbeats on use days vs abstinence days. Mental Health Policy: A new discussion piece revisits whether cannabis-associated psychosis is biologically distinct from schizophrenia, as a major advocacy group warns Massachusetts voters about a ballot push to roll back legalization. Regulation Watch: The UK Advertising Standards Authority added Katie Price-backed “Supreme CBD” to its non-compliant list over repeated health-claim concerns. Driving Under the Influence: Santa Monica police plan a DUI checkpoint and remind drivers that cannabis impairment is illegal. Market Updates: Ohio pricing data shows cannabis remains far pricier than Michigan, while Ohio’s CERTIFIED opens a new Reynoldsburg dispensary. Public Health Messaging: Ghana’s NACOC chief urges youth to reject cannabis myths, stressing risks to memory and decision-making. Enforcement: Police in Dublin charged a man after a €1.2M cannabis haul tied to a burglary.

Medical Policy Watch: Thailand’s cannabis rules have shifted again, moving from broad decriminalization toward a tightly regulated medical-only framework, with access now more specific for Bangkok dispensaries. Regulatory Oversight: Massachusetts’ Cannabis Control Commission completed a shelf audit of THC potency labels, flagging products that fall outside accurate ranges and moving to stop further sales of noncompliant flower. Enforcement & Compliance: Maryland cracked down on unlicensed cannabis sales in St. Mary’s County, seizing illicit flower and thousands of non-compliant THC products from three tobacco/smoke shops. Industry & Finance: Glass House Brands reported Q2 2026 results, highlighting record biomass production and continuing its 2026 outlook after deconsolidating its retail business. Public Safety: A UK court jailed a driver who fatally struck a woman while behind the wheel with cannabis in his system, underscoring ongoing risks around impaired driving. Business Deal: NFP (Aon) acquired Frontier Risk Group’s cannabis retail insurance business, expanding coverage for regulated cannabis operators. Research & Care: A study reports medical cannabis-based products improved endometriosis pain, sleep, and anxiety while reducing opioid use over 24 months.

Regulation Watch: Massachusetts Cannabis Control Commission says most THC potency label checks on flower products were within range, but noncompliant items will be flagged and stopped from further sales. Retail Expansion: NatureMed opened its third Kentucky medical cannabis dispensary in Murray, aiming to cut travel time for patients and offering flower, edibles, and vaporizers. Clinical & Safety: A CDC update attributes a sharp rise in ER visits for cannabis hyperemesis syndrome to a new dedicated diagnosis code (introduced Oct. 1, 2025), not necessarily a true outbreak. Medical Evidence: UK registry data reports sustained improvements for endometriosis patients using cannabis-based medicinal products, including reduced pain and lower opioid use. Policy & Access: Georgia medical cannabis enrollment jumped after lawmakers expanded the program in May, adding more qualifying conditions and allowing botanical cannabis and higher-THC products. Research Signals: A new study links cannabis use with fewer premature heartbeats on use days in regular users, suggesting a potential heart rhythm effect worth watching. Enforcement: Nigeria customs seized cannabis sativa worth about N2.09bn, while other drug actions in Malaysia highlighted large multi-drug seizures and asset forfeitures.

Medical Cannabis Access: Mississippi’s Sweet Life Canna Co. says its Long Beach cultivation facility is now supplying 135 dispensaries statewide, aiming for patient-focused production and GMP certification. Local Business Launch: Kentucky’s NatureMed held a ribbon-cutting for Murray’s new medical cannabis dispensary, following legalization under Senate Bill 47. Retail Expansion Tech: Arizona’s Sun Lakes Country Club plans an on-site marijuana kiosk with “Easy Mode” ordering and select complimentary delivery, partnering with Life Is Chill and LoveBud. Public Safety & Enforcement: Illinois police are stepping up Labor Day traffic enforcement targeting impaired driving by alcohol, cannabis, and other drugs. Illicit Market Crackdown: Ontario Provincial Police and Toronto officers seized nearly 4,000 cannabis plants and $1.5M in Brampton, citing no Health Canada registrations or licences. Health Research: A UCSF-led study found inhaled cannabis users had about 9% fewer premature heartbeats on days they used vs days they abstained. Hemp Quality Check: A 2026 roundup highlights TribeTokes as best for transparent, batch-level lab testing via COAs.

PTSD Treatment Breakthrough: A Nature Medicine trial found prescription dronabinol (THC) cut PTSD nightmare frequency and intensity, with over a third reporting no nightmares after 10 weeks. Cardiovascular Research: UC San Francisco-led research in the Journal of the American College of Cardiology reported inhaled cannabis was linked to about 9% fewer premature heartbeats on days participants used versus days they abstained. Federal Research Funding (Canada): Canada announced $24M for the Canadian Cannabis and Brain Health Consortium to study cannabis effects on the brain across ages, including epilepsy, anxiety, PTSD, sleep, mental health, and pregnancy. Market & Corporate Moves: Organigram said its European acquisition of Germany’s Sanity Group boosted quarterly revenues by about $38M and reshaped its growth strategy. Regulatory/Policy Pressure (Texas): Texas health officials warned that some hemp-derived products may still pose risks even after delta-8 and other synthetically derived cannabinoids were reclassified as Schedule 1. Business Rebrand: Splash Beverage Group plans to rename itself Endovia Health Sciences, positioning as a cannabinoid health sciences platform.

Illegal Cultivation Crackdown (Nevada County, CA): Nevada County Sheriff’s detectives and California wildlife officers hit 21 suspected illegal cannabis sites, destroying 4,989 plants, seizing 1,801.4 lbs of processed cannabis, and arresting nine people; investigators also flagged water pollution, trash, environmental damage, dangerous pesticides, and other drug activity. Corporate Power Play (Curaleaf vs. Aurora): Curaleaf launched a hostile takeover bid for Aurora Cannabis, offering $4 per share (cash + stock) and pitching a 45% premium, while Aurora says it received letters from Curaleaf and is reviewing the proposal under fiduciary duties. Emergency Care Signal (CHS): A CDC report says ED visits involving cannabis hyperemesis syndrome jumped after a CHS-specific ICD-10 code rolled out in Oct. 2025, suggesting the condition’s burden was previously underestimated. Research Watch (Glioblastoma): Lab findings suggest some cannabinoids, including CBD, may protect glioblastoma cells from chemotherapy and radiation-induced cell death—raising caution for anticancer assumptions. Regulatory/Access (Texas hemp THC): A federal judge denied an emergency bid to pause Texas’ ban on most hemp-derived THC products while the lawsuit continues. Local Policy (Buffalo County, NE): Zoning rules passed could block medical marijuana processing/distribution tied to CBD and other cannabis products, putting licenses at risk for local operators. Public Health & Safety (Georgia): Georgia’s medical cannabis registry surged after a new law expanded qualifying conditions and changed THC potency rules. Aviation Incident (Air India): Reports say an Air India pilot tested positive for cannabis after a flight plunge injured 24 passengers. Criminal Justice (UK drug-driving): A woman admitted driving with THC above the legal limit after being stopped when her car smelled of cannabis.

M&A Watch: Curaleaf says it plans to launch an unsolicited takeover bid for Aurora Cannabis at $4.00 per share (mix of Curaleaf shares plus cash), while Aurora pushes back on the terms and notes the bid is capped below recent trading levels. Policy & Access: CMS is testing a Medicare pathway that could let eligible beneficiaries receive qualifying hemp-derived products through participating health-care organizations—raising fresh stakes for Michigan’s CBD rules. Texas Hemp Crackdown: A federal judge refused to pause Texas’s ban on several hemp-derived THC products, keeping the restrictions in place while the lawsuit moves forward. Clinical Research: A German trial reports prescription THC (dronabinol) reduced severe PTSD-related nightmares, with many participants responding and some seeing complete disappearance. Product/Market Moves: Village Farms rolled out new easy-pour Super Toast ground-flower pouches in Canada, aiming to improve consumer convenience and visibility. Industry/Compliance: Clean Remedies says it’s adjusting its product lineup in response to evolving federal regulations.